You are here

Latest news & updates

30 September 2021
Interim decisions and invitation for further comment. Closing date: 1 November 2021
28 September 2021
On 27 September 2021 the TGA granted provisional determination to Roche Products Pty Ltd in relation to the COVID-19 treatment tocilizumab (ACTEMRA).
28 September 2021
The TGA has issued seven infringement notices totalling $18,648 to the individual responsible for the Invigorate Labs website, for alleged breaches that relate to the advertising of products containing cannabidiol (CBD).
27 September 2021
Australian Public Assessment Report for Fostemsavir trometamol
24 September 2021
Submissions published and summarised as part of a consultation on clarifying the regulation of 'residual activity' claims for disinfectants.
29 September 2021
A new Data Protection Scheme is now available for assessed listed medicine applications.
22 November 2021
Updated guidance to reflect new amendments made to the regulations.
22 November 2021
Updated guidance to reflect new amendments made to the regulations.
24 September 2021
Australian prescription medicine decision summary
22 September 2021
The TGA has issued two infringement notices totalling $26,640 to Tianda Pharmaceuticals Australia Pty Ltd for alleged unlawful advertising of a listed medicine in relation to COVID-19.

Pages

Subscribe to Latest news & updates